Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Shengtai Pharmaceutical, Inc. | Financial_Report.xls |
| 10-Q - FORM 10-Q - Shengtai Pharmaceutical, Inc. | v301332_10q.htm |
| EX-31.1 - EXHIBIT 31.1 - Shengtai Pharmaceutical, Inc. | v301332_ex31-1.htm |
| EX-32.2 - EXHIBIT 32.2 - Shengtai Pharmaceutical, Inc. | v301332_ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - Shengtai Pharmaceutical, Inc. | v301332_ex31-2.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Shengtai Pharmaceutical, Inc., the “Company,” on Form 10-Q for the quarter ended December 31, 2011, as filed with the Securities and Exchange Commission on the date hereof, the “Report,” I, Qingtai Liu, the Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: February 14, 2012 | /s/ Qingtai Liu |
| Qingtai Liu | |
| Title: Chief Executive Officer | |
| (Principal Executive Officer) |